PSS World Medical Inc. (PSSI)

PSSI (NASDAQ:Wholesale)
$28.92
neg -0.03
-0.10%
Today's Range: 28.73 - 28.96 | PSSI Avg Daily Volume: 1,450,400
Last Update: 02/21/13 - 4:00 PM EST
Volume: 4,176,009
YTD Performance: 0.14%
Open: $28.95
Previous Close: $28.95
52 Week Range: $18.64 - $28.99
Oustanding Shares: 50,328,830
Market Cap: 1,455,509,764
6-Month Chart
TheStreet Ratings Grade for PSSI
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 0 0 0 0
Moderate Buy 0 0 0 0
Hold 5 6 6 6
Moderate Sell 1 1 1 1
Strong Sell 0 0 0 0
Mean Rec. 3.17 3.14 3.14 3.14
Latest Dividend: 0.00
Latest Dividend Yield: 0.00%
Dividend Ex-Date: 12/31/69
Price Earnings Ratio: 23.51
Price Earnings Comparisons:
PSSI Sector Avg. S&P 500
23.51 17.50 17.70
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
1.62% 18.87% 37.45%
GROWTH 12 Mo 3 Yr CAGR
Revenue 3.30 0.08 0.02
Net Income -0.20 0.28 0.09
EPS 4.50 0.47 0.14
Earnings for PSSI:
EBITDA 0.18B
Revenue 2.10B
Average Earnings Estimates
Qtr (12/12) Qtr (03/13) FY (03/13) FY (03/14)
Average Estimate $0.30 $0.33 $1.09 $1.36
Number of Analysts 5 6 7 7
High Estimate $0.31 $0.38 $1.14 $1.50
Low Estimate $0.28 $0.30 $1.05 $1.27
Prior Year $0.38 $0.38 $1.38 $1.09
Growth Rate (Year over Year) -21.58% -12.28% -20.81% 24.84%
Update Chart
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands

bearishPSS World Medical downgraded at UBS

Nov 8, 2012 | 8:21 AM EST

PSSI was downgraded to Neutral from Buy, UBS said. $29 price target. 10Q reveals inline results. 

bullishPSS World Medical rated new Buy at UBS

May 21, 2012 | 8:23 AM EDT

PSSI was initiated with a Buy rating, UBS said.  $26 price target.  Market has overcorrected the stock price. 

bearishPSS World Medical downgraded at Baird

May 11, 2012 | 6:43 AM EDT

PSSI was downgraded from Outperform to Neutral, Robert Baird said. $21 price target. Company missed expectations again and lacks near-term catalysts. 

How To Heal a Portfolio

By

John Reese

 | Aug 30, 2011 | 1:30 PM EDT

Medical equipment makers and suppliers could be just the right remedy.

Columnist Conversation / Market Updates

Bullish Case for the Bonds (TLT)
By

Toni Hansen

 | Jun 20, 2013 | 1:22 AM EDT
Has the TLT finally found support? More importantly, can it hold it? I think there is a case to be made for it... Here i...

Texas's power grid pours on the coal
By

Glenn Williams

 | Jun 19, 2013 | 8:36 PM EDT
Faced with a capacity shortfall and possible energy shortages, Texas power producers dusted off some old plants and put ...
See more »

Our Tweets

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.